Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResApp Grants Option to Consumer Health Division of Sanofi, page-87

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 87 Last

Share
Profile

Follow
applesanddiamonds

612 Posts.

141

15/11/19

12:20

Post #: 41445289
Share

Originally posted by RNClarke: ↑

This is a good start, Sanofi are global behemoths clearly liking what they see and want to explore a commercial deal.

The option is for a consumer facing application, unlikely to be used in a telehealth setting.

Another company with a breakthrough platform technology I’m invested in is also taking a similar route, negotiating their technology for a single vertical and geography. It's a way of keeping the big multinationals honest and transparent.

Giving global rights to a single company for ‘x’ amount can stall a rollout. A technology like ResApp’s needs multiple commercial partners across different verticals to fast track to market.

Expand

Fully agree.
My first thoughts gave me excitement.

The big boys are wanting ResApp to get into bed with THEM....!!!!
We are not seeking out the big boys....they are coming to us....!!!!!!

Pure gold...!!!

RAP Price at posting: 27.5¢ Sentiment: Buy Disclosure: Held
11 Upvote

1 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

There are more pages in this discussion • 178 more messages in this thread...

First 87 Last

Add RAP (ASX) to my watchlist